Zobrazeno 1 - 10
of 26
pro vyhledávání: '"William J. Moran"'
Autor:
Everett E. Vokes, Merrill S. Kies, Mark Kozloff, Ralph R. Weichselbaum, William R. Panje, Bharat B. Mittal, Howard Pelzer, William J. Moran, Daniel J. Haraf, Barry L. Wenig, Rosemarie Mick
Publikováno v:
Journal of Clinical Oncology. 13:876-883
PURPOSE To determine survival rates and the pattern of failure in head and neck cancer patients treated with induction chemotherapy, limited surgery and concomitant chemoradiotherapy. PATIENTS AND METHODS Three cycles of induction chemotherapy with c
Autor:
Michael E. Goldman, William R. Panje, Michael A. Beckett, Susan Ahmed-Swan, Ralph R. Weichselbaum, Azhar Awan, William J. Moran, Allen G. Tybor, E. Farhangi, Everett E. Vokes, Michael A. Simon, Srinivasan Vijayakumar, James B. Nachman
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:313-319
The radiobiological parameters of 33 tumor cell lines were studied in biopsy samples obtained from patients prior to radiotherapy. Epithelial tumor cells derived from head and neck cancer patients were more radioresistant than tumor cell lines derive
Autor:
Mark Kozloff, Everett E. Vokes, Rosemarie Mick, Ralph R. Weichselbaum, William J. Moran, Harold G. Sutton, Allen G. Tybor, William R. Panje, Michael D. Goldman
Publikováno v:
Cancer. 66:206-213
Two regimens of neoadjuvant chemotherapy for previously untreated patients with locally advanced head and neck cancer were compared with the goal of identifying a regimen with a greater than 50% complete response (CR) rate. Patients with a performanc
Publikováno v:
Oncology reports. 5(2)
Osteoradionecrosis of the jaws is a severe complication of radiotherapy in the treatment of the head and neck neoplasms. The literature indicates a recent decline in the reported incidence of this complication. The purpose of this study was to furthe
Publikováno v:
Archives of otolaryngology--headneck surgery. 122(1)
Objective: To evaluate the use of endosseous transcutaneous implants to retain removable facial prostheses for the rehabilitation of orbital defects. Setting: Tertiary referral center. Patients: Six patients with a history of facial defects secondary
Autor:
M. S. Kies, T. D. Sheehan, I. Athanasiadis, Daniel J. Haraf, J M McEvilly, Ralph R. Weichselbaum, Bharat B. Mittal, Mark Kozloff, Harold J. Pelzer, William J. Moran, William R. Panje, E. E. Yokes, Barry L. Wenig, Rosemarie Mick
Publikováno v:
Cancer Treatment An Update ISBN: 9782817807676
The combination of Cisplatin and Infusional fluorouracil has been widely used for the treatment of locally advanced squamous head and neck cancer, at diagnosis and recurrence [1–4]. When applied in the Neo-Adjuvant setting, it has resulted in high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccf04f2c83f8747082abf16a3e33ebf8
https://doi.org/10.1007/978-2-8178-0765-2_39
https://doi.org/10.1007/978-2-8178-0765-2_39
Publikováno v:
Archives of otolaryngology--headneck surgery. 119(6)
• Review of the otolaryngologic literature reveals no case reports of mycosis fungoides involving the esophagus. Postmortem studies report 12 cases of esophageal involvement in 131 autopsies of patients with mycosis fungoides. We describe a 54-year
Autor:
Everett E. Vokes, Daniel J. Haraf, R. R. Weich selbaum, Mark Kozloff, Rosemarie Mick, M. D. Goldman, N. J. Clendeninn, William R. Panje, Mary Collier, William J. Moran, J M McEvilly
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 3(1)
To increase the complete remission (CR) rate achieved with two cycles of cisplatin, continuous infusion fluorouracil (5-FU) and oral leucovorin (PFL) we added two antifolate drugs, methotrexate (MTX) and the lipophilic piritrexim (PTX), to the combin
Autor:
William R. Panje, William J. Moran
Publikováno v:
Head & Neck Surgery. 8:309-312
In this report 21 cases of primary malignant melanoma arising from the mucosa of the upper aerodigestive tract are reviewed. The patients ranged in age from 30 to 86; mean age was 67 years. There were 10 men and 11 women. All but one patient were whi
Autor:
Allen G. Tybor, Everett E. Vokes, Azhar Awan, Richard L. Schilsky, William J. Moran, M. D. Goldman, William R. Panje, Rosemarie Mick, Ralph R. Weichselbaum
Publikováno v:
Journal of Clinical Oncology. 7:761-768
Hydroxyurea and fluorouracil (5-FU) are active cytotoxic drugs in head and neck cancer and have shown synergistic activity in vitro. Both drugs also act as radiosensitizers. Therefore, we administered radiotherapy at daily fractions of 180 to 200 cGy